OR WAIT null SECS
August 28, 2020
Thermo Fisher Scientific is increasing access to cry-electron microscopy with the help of contract research organizations.
August 26, 2020
The contract is valued at $106.3 million and is supported by Operation Warp Speed.
Mapp has selected Avid to provide process transfer, scale-up, and clinical manufacturing services for one of its development programs for a novel antiviral drug candidate.
Müller + Müller will become part of DWK upon closing in September 2020 and will continue to function under the same name and management.
August 20, 2020
Bristol Myers Squibb will handle the development and commercialization of DF6002 and its related products worldwide, including strategic decisions, regulatory responsibilities, funding, and manufacturing.
The collaboration will increase the supply of the potential treatment to at least three and a half times the current capacity.
The deal is expected to close during the second half of 2020.
August 18, 2020
The acquisition will give Sanofi access to Principia’s Bruton tyrosine kinase (BTK) inhibitors to add to its portfolio of next-generation transformative treatments for autoimmune diseases.
The cell banks were created using current good manufacturing practices and can be used each time CombiGene produces new plasmids for the production of its gene therapy, CG01.
August 13, 2020
SK bioscience will manufacture the vaccine antigen component for use in the final drug product at its vaccine facility in Andong L-house, South Korea.